Pharmacogenetic Influence of LOC387715/HTRA1 on the Efficacy of Bevacizumab Treatment for Age-Related Macular Degeneration in a Korean Population

PURPOSE: The purpose of this study was to determine the pharmacogenetic effects of complement factor H (CFH) Y402H, LOC387715 and high-temperature requirement factor A1 (HTRA1) genotypes on the treatment of exudative age-related macular degeneration (AMD) by intravitreal bevacizumab injection in a K...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Haeng Ku, Yoon, Myung Hun, Lee, Dae Hyun, Chin, Hee Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506814/
https://www.ncbi.nlm.nih.gov/pubmed/23204795
http://dx.doi.org/10.3341/kjo.2012.26.6.414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506814/
https://www.ncbi.nlm.nih.gov/pubmed/23204795
http://dx.doi.org/10.3341/kjo.2012.26.6.414

Ejemplares similares